Stockreport

Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF Net loss: US$35.7m (loss widened by 53% from 1Q 2023). US$1.01 loss per share (further deteriorated from US$0.88 loss in 1Q 2023). All figures shown in the chart ab [Read more]